Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity
NCT02382068Withdrawn
- Start
- Aug 2014
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of dexamethasone in ototoxicity. Primary endpoint: Change in score of pure tone audiometry of conventional and high-frequency ranges. Planned start Aug 2014; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT02382068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382068.